Rainbow Seed Fund News

CytoSeek Ltd, a discovery-stage biotech company developing the next generation of cell therapies to treat cancer, is excited to announce today the completion of a £3.57M ($5M) funding round. The funding will support the development of CytoSeek’s Artificial Membrane-Binding Protein (AMBP) platform for its internal cell therapy programs and the development and out-licence of its […]

read more

Non-invasive genetic test enables physicians to assess an individual’s risk of cognitive decline due to Alzheimer’s from a simple saliva sample provided from home Test can guide lifestyle interventions to potentially slow disease progression 24th February 2021: Oxford and Manchester, UK. Cytox Ltd, which provides non- invasive, risk assessment and patient stratification tools for Alzheimer’s disease (AD) and dementia, […]

read more

 The second round of funding will enable the company to commence the development of the hardware platform for its tests. Birmingham-based Linear Diagnostics Ltd has secured £800,000 from the Midlands Engine Investment Fund (MEIF)and other investors in the company’s second round of funding. The finance will facilitate the ongoing development of the company’s high-speed […]

read more

1 2 3 15